Flexuspine, Inc. v. Globus Medical, Inc., No. 6:15-cv-00201 (E.D. Tex. Aug. 5, 2016)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
On April 8 , 2016 , the Court issued an order construing the disputed claim terms of United States Patent Numbers 7,204,853 (“the ’853 Patent”), 7,316,714 (“the ’714 patent”), 7,909,869 (“the ’869 Patent”), 8,123,810 (“the ’810 Patent”), and 8,647,386 (“the ’386 Patent”) asserted in this suit by Plaintiff Flexuspine, Inc. (“Plaintiff”) against Defendant Globus Medical, Inc. (“Defendant”).
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error